Spin-offs and Entrepreneurship

Spin-off companies

Notice: the definition of a spin-off may be different for each institution. Sometimes limited to companies initiated around a technology licensed by the institution, the definition may be wider and include also companies initiated by students after graduation. For this reason, before any comparison, a clarification must be made.

Please note that the Swiss association of technology transfer professionals swiTT publishes each year statistics on common definitions.

1996 Mar GapOptique Optical Fibers caracterization
1998 Oct Creation of Unitec Office of technology transfer Uni Geneva
1999 May GeneBio BioInformatics
  Nov NovImmune Immunology
2000 Nov GeneProt Proteomics
  Mar LATL Artificial language
2001 Mar Metaread Computer agents
  Mar Genesoft New drug therapies using chromosome expression
2002 Apr Dictagène Vaccins
  Nov Athelas Pharma testing
2003 Apr Nano Bridging Molecules Implants surface treatment
  Apr IdQuantique Quantum cryptography
  May Endosense1 Treatment of atrial fibrillation
2004 Mar Anecova Assisted reproductive technology
  Jun Phasis Nano level marking for anti-counterfeiting
  Dec Funzyme Biotechnologies Protein capture
2005 Mar Miradreams Software tools for virtual fashion designer
  Jun Anteleon Watermarking
2006 Mar Epithelix Provider of In Vitro Reconstituted Epithelium
  Jul ViaVac Vaccines management software
  Sep Arisgen Chemical modification of proteins and peptides
  Nov GenKyotex2 Age-related diseases
2007 Mar Antia Therapeutics3 Hyperthermic cancer treatment 
  Aug CNX Therapeutics in neuropathology
2008 Mar MaestroHeart 1 Treatment of atrial fibrillation
2009 Sep Phistem Cancer treatment 
2010 Jun Stemergie2 cancer stem cells (CSC) technology platform
  Jul Microleman Laser micro-colimator for researching cells repair
  Aug Bard1ag2 Diagnostic test for lung cancer
2011 May Neurix2 Development and exploitation of engineered neural tissues  
  Jul PVsyst Software for photovoltaic systems  
  Sep Apidel Drug delivery  
2013 Feb Amal Therapeutics2 Cancer immunotherapy
  Apr EMAGine2 Ophtalmology
  Dec Galkem Cancer Therapeutics
2014 Aug Plair Advanced aerosol particle detection  
2015 Dec GEDECE Content identification and authentication of physical objects using image processing techniques  
    ID-Gene Ecodiagnostics DNA-based tests for environmental bioassessment and biomonitoring  
2016 May ABCDx Development of diagnostic marquers for cardiovascular diseases and strokes
  Jun Cell-Caps2 Innovative materials and technologies for immuno-isolation and transplantation of living cells
  Dec SwissDeCode Confirm food authenticity, safety and origin using DNA kits easy to use
2017 Jan HPlus Therapeutics Small molecule inhibitors of proton channels for the treatment of cancer
  Mar Kylys Biomolecules
  Apr ReAlliance 1
2018 Apr Immuthes Immune therapeutics for human health
  Aug Dotphoton Groundbreaking quantum image compression technology
  Dec Endotelix Diagnostic and treatment for Antiphospholipid Syndrome
2019 Jul MPC Therapeutics
Mitochondrial pyruvate carrier inhibitors 
  Oct FoRx Therapeutics  Anti-cancer drugs
  Oct Orion Biotechnology Switzerland Chemokine analogue-based therapeutics
  Nov Antion biosciences2 Molecular therapies
2020 Jan Adiposs Contrast agents for early detection of cachexia
  Apr MaxiVAX2 Cancer immunotheraphy
  Jul Healsye Development and distribution of software for hospitals
  Aug TestMate Health (ribolifeDx) DIY Home test kits for Sexually Transmissible Diseases
  Nov Kryabio Drug delivery facilitating enhanced absorption of co-administered therapies
2021 May Windshape4 Design, manufacture and operation of digital wind facilities
  Aug Asterivir5
New treatment against Covid-19
New Computer Interaction Laboratory
  Dec Schedul81
Software for automatized planning generation
2022 Jan HeadToToe mHealth3
Mobile health platform which makes medical guidance dissemination within health institutions
  Mar Fluosphera1 Non animal systemic alternative for drug discovery
  May Heketiss2 Adipose-derived stem cell driven skin regeneration
  Oct Adoram1 Allosteric modulators of a validated cancer immunotherapy target, A2AR

1University Hospitals of Geneva

2Combination of University and University Hospitals of Geneva

3Combination of University and University Hospitals of Geneva and EPFL

4University of Applied Sciences Geneva